Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001804350-20-000001
Filing Date
2020-02-24
Accepted
2020-02-24 12:38:01
Documents
2
Group Members
LEVEL ONE PARTNERS, LLCMOLLY G. HARDIE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sched13g.htm SC 13G 16740
2 SCHEDULE 13G schedule13G.pdf SC 13G 51861
  Complete submission text file 0001804350-20-000001.txt   89800
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Subject) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79364 | Film No.: 20643197
SIC: 2834 Pharmaceutical Preparations

Mailing Address 210 RIDGE MCINTIRE ROAD, SUITE 350 CHARLOTTESVILLE VA 22903
Business Address
Hardie Robert D. (Filed by) CIK: 0001804350 (see all company filings)

Type: SC 13G